查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1859920

Metformin Hydrochloride：全球市场份额和排名、总销售额和需求预测（2025-2031 年）

Metformin Hydrochloride - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 116 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球Metformin Hydrochloride市场预计在 2024 年达到 3.91 亿美元，预计到 2031 年将达到 5.84 亿美元，2025 年至 2031 年的复合年增长率为 6.3%。

本报告对近期有关Metformin Hydrochloride跨境产业布局、资本配置模式、区域经济相互依存关係和供应链重组的关税调整和国际战略反制措施进行了全面评估。

Metformin Hydrochloride是生产成品Metformin Hydrochloride製剂的原料。本品为Metformin Hydrochloride原料药（API）。成品Metformin Hydrochloride是一种口服降血糖药，用于治疗第二型糖尿病。Metformin Hydrochloride（N,N-二甲基亚氨基二碳酰亚胺酰胺盐酸盐）在化学和药理学上与其他口服降血糖药物无关。Metformin Hydrochloride为白色至淡黄色结晶质化合物，分子式为C4H11N5HCl，分子量为165.63。Metformin Hydrochloride易溶于水，几乎不溶于丙酮、乙醚和氯仿。本报告提供有关盐酸二甲双胍活性药物成分（API）的统计数据。 2024年，全球Metformin Hydrochloride市场规模达到约66,400吨，全球平均市场价格约每吨5,894美元。

Metformin Hydrochloride是一种广泛使用的口服降血糖药物，主要用于治疗第二型糖尿病。它属于双胍类药物，透过抑制肝醣异生、减少肠道葡萄糖吸收和提高週边组织胰岛素敏感性发挥作用。其确切的疗效、安全性以及低廉的价格使其成为全球数百万患者的一线治疗药物。全球市场高度标准化，产能约12万吨，毛利率相对较低，为6%至20%，单一生产线的产能通常在3000至5000吨之间。这反映出一个成熟的、大规模的医药中间体市场。

上游工程产业链始于二甲胺盐酸盐和双氰胺等原料，这些原料经化学合成生成二甲双胍碱。此中间体随后经盐酸结晶提纯，Metformin Hydrochloride。在中游环节，生产商将原料药（API）加工成原料药，或供应给製剂生产商。下游环节，学名药生产商生产片剂、缓释性以及与其他抗糖尿病药物的固定剂量复方组合药物，占据了大部分需求。该行业结构的特点是原料药生产商之间竞争激烈，尤其是在中国和印度，这两个国家供应了全球大部分的原料药需求。

市场成长的关键驱动因素是全球第2型糖尿病盛行率的不断上升，这主要归因于人口老化、缺乏运动以及饮食习惯的改变，尤其是在开发中国家。新兴国家医疗保健服务的改善持续扩大了二甲双胍类治疗方法的患者群体。此外，国际指引广泛认可二甲双胍作为糖尿病治疗的基石，也确保了其稳定的需求。其他驱动因素包括探索其在非糖尿病领域的应用，例如治疗卵巢症候群（PCOS），以及在老龄化相关疾病和肿瘤治疗中的潜在用途，进一步拓宽了其临床应用范围。儘管面临激烈的价格竞争和较低的利润率，二甲双胍在糖尿病治疗中的关键作用仍能确保其市场的长期稳定。

本报告旨在按地区/国家、类型和应用对全球Metformin Hydrochloride市场进行全面分析，重点关注总销售量、收入、价格、市场份额和主要企业的排名。

本报告以销售量（吨）和收入（百万美元）为单位，对Metformin Hydrochloride市场规模、估算和预测进行了呈现，以2024年为基准年，并包含了2020年至2031年期间的历史数据和预测数据。本报告运用定量和定性分析，帮助读者制定业务/成长策略、评估市场竞争、分析自身在当前市场中的地位，并就Metformin Hydrochloride做出明智的商业决策。

市场区隔

公司

  • Wanbury
  • USV
  • Shouguang Fukang Pharmaceutical
  • Vistin Pharma
  • Ningxia Hengkang Technology
  • Keyuan Pharmaceutical
  • FARMHISPANIA GROUP
  • Harman Finochem
  • Shijiazhuang Polee Pharmaceutical
  • Aarti Drugs
  • Exemed Pharmaceuticals
  • Granules

按类型分類的细分市场

  • 盐酸二甲双胍
  • 二甲双胍

应用领域

  • Metformin Hydrochloride片
  • Metformin Hydrochloride缓释片
  • 其他的

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Metformin Hydrochloride was estimated to be worth US$ 391 million in 2024 and is forecast to a readjusted size of US$ 584 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Metformin Hydrochloride cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Metformin hydrochloride is the raw material of finished product metformin hydrochloride drugs. That is the API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in the management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystalline compound with a molecular formula of C4H11N5*HCL and a molecular weight of 165.63. Metformin hydrochloride is freely soluble in water and is practically insoluble in acetone, ether and chloroform. In this report, our statistics is given by metformin hydrochloride API.In 2024, global Metformin Hydrochloride reached approximately 66400 MT, with an average global market price of around US$ 5894 per MT.

Metformin Hydrochloride is a widely used oral antihyperglycemic drug, primarily prescribed for the treatment of type 2 diabetes. It belongs to the biguanide class and works by reducing hepatic glucose production, decreasing intestinal absorption of glucose, and improving insulin sensitivity in peripheral tissues. Its well-established efficacy, safety profile, and low cost have made it the first-line therapy for millions of patients worldwide. The global market is highly standardized, with a production capacity of about 120,000 tons, a relatively thin gross profit margin of 6%-20%, and single-line production capacities commonly in the range of 3,000-5,000 tons, reflecting a mature, large-scale pharmaceutical intermediate market.

The industry chain begins upstream with raw materials such as dimethylamine hydrochloride and dicyandiamide, which undergo chemical synthesis to produce metformin base. This intermediate is further crystallized and refined with hydrochloric acid to yield metformin hydrochloride in pharmaceutical-grade quality. Midstream, manufacturers formulate the active pharmaceutical ingredient (API) into bulk drug products or supply it to formulation companies. Downstream, the demand is dominated by generic drug manufacturers producing tablets, extended-release formulations, and fixed-dose combinations with other antidiabetic drugs. The industry structure is characterized by significant competition among bulk producers, especially in China and India, which supply the majority of global API demand.

Key market drivers include the growing global prevalence of type 2 diabetes, driven by aging populations, sedentary lifestyles, and dietary changes, particularly in developing countries. Increasing healthcare access in emerging economies continues to expand the patient base for metformin-based therapies. Moreover, the widespread acceptance of metformin as the cornerstone of diabetes management by international guidelines ensures consistent demand. Additional drivers include its applications beyond diabetes, such as polycystic ovary syndrome (PCOS) treatment and research into potential uses in aging-related conditions and oncology, which further broaden its clinical relevance. Despite competitive pricing pressure and low margins, its indispensable role in diabetes care secures long-term market stability.

This report aims to provide a comprehensive presentation of the global market for Metformin Hydrochloride, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Metformin Hydrochloride by region & country, by Type, and by Application.

The Metformin Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metformin Hydrochloride.

Market Segmentation

By Company

  • Wanbury
  • USV
  • Shouguang Fukang Pharmaceutical
  • Vistin Pharma
  • Ningxia Hengkang Technology
  • Keyuan Pharmaceutical
  • FARMHISPANIA GROUP
  • Harman Finochem
  • Shijiazhuang Polee Pharmaceutical
  • Aarti Drugs
  • Exemed Pharmaceuticals
  • Granules

Segment by Type

  • Metformin HCL
  • Metformin DC

Segment by Application

  • Metformin Hydrochloride Tablets
  • Metformin Hydrochloride Extended-Release Tablets
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Metformin Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Metformin Hydrochloride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Metformin Hydrochloride in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Metformin Hydrochloride Product Introduction
  • 1.2 Global Metformin Hydrochloride Market Size Forecast
    • 1.2.1 Global Metformin Hydrochloride Sales Value (2020-2031)
    • 1.2.2 Global Metformin Hydrochloride Sales Volume (2020-2031)
    • 1.2.3 Global Metformin Hydrochloride Sales Price (2020-2031)
  • 1.3 Metformin Hydrochloride Market Trends & Drivers
    • 1.3.1 Metformin Hydrochloride Industry Trends
    • 1.3.2 Metformin Hydrochloride Market Drivers & Opportunity
    • 1.3.3 Metformin Hydrochloride Market Challenges
    • 1.3.4 Metformin Hydrochloride Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Metformin Hydrochloride Players Revenue Ranking (2024)
  • 2.2 Global Metformin Hydrochloride Revenue by Company (2020-2025)
  • 2.3 Global Metformin Hydrochloride Players Sales Volume Ranking (2024)
  • 2.4 Global Metformin Hydrochloride Sales Volume by Company Players (2020-2025)
  • 2.5 Global Metformin Hydrochloride Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Metformin Hydrochloride Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Metformin Hydrochloride Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Metformin Hydrochloride
  • 2.9 Metformin Hydrochloride Market Competitive Analysis
    • 2.9.1 Metformin Hydrochloride Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Metformin Hydrochloride Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metformin Hydrochloride as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Metformin HCL
    • 3.1.2 Metformin DC
  • 3.2 Global Metformin Hydrochloride Sales Value by Type
    • 3.2.1 Global Metformin Hydrochloride Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Metformin Hydrochloride Sales Value, by Type (2020-2031)
    • 3.2.3 Global Metformin Hydrochloride Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Metformin Hydrochloride Sales Volume by Type
    • 3.3.1 Global Metformin Hydrochloride Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Metformin Hydrochloride Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Metformin Hydrochloride Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Metformin Hydrochloride Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Metformin Hydrochloride Tablets
    • 4.1.2 Metformin Hydrochloride Extended-Release Tablets
    • 4.1.3 Others
  • 4.2 Global Metformin Hydrochloride Sales Value by Application
    • 4.2.1 Global Metformin Hydrochloride Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Metformin Hydrochloride Sales Value, by Application (2020-2031)
    • 4.2.3 Global Metformin Hydrochloride Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Metformin Hydrochloride Sales Volume by Application
    • 4.3.1 Global Metformin Hydrochloride Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Metformin Hydrochloride Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Metformin Hydrochloride Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Metformin Hydrochloride Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Metformin Hydrochloride Sales Value by Region
    • 5.1.1 Global Metformin Hydrochloride Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Metformin Hydrochloride Sales Value by Region (2020-2025)
    • 5.1.3 Global Metformin Hydrochloride Sales Value by Region (2026-2031)
    • 5.1.4 Global Metformin Hydrochloride Sales Value by Region (%), (2020-2031)
  • 5.2 Global Metformin Hydrochloride Sales Volume by Region
    • 5.2.1 Global Metformin Hydrochloride Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Metformin Hydrochloride Sales Volume by Region (2020-2025)
    • 5.2.3 Global Metformin Hydrochloride Sales Volume by Region (2026-2031)
    • 5.2.4 Global Metformin Hydrochloride Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Metformin Hydrochloride Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Metformin Hydrochloride Sales Value, 2020-2031
    • 5.4.2 North America Metformin Hydrochloride Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Metformin Hydrochloride Sales Value, 2020-2031
    • 5.5.2 Europe Metformin Hydrochloride Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Metformin Hydrochloride Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Metformin Hydrochloride Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Metformin Hydrochloride Sales Value, 2020-2031
    • 5.7.2 South America Metformin Hydrochloride Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Metformin Hydrochloride Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Metformin Hydrochloride Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Metformin Hydrochloride Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Metformin Hydrochloride Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Metformin Hydrochloride Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Metformin Hydrochloride Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Metformin Hydrochloride Sales Value, 2020-2031
    • 6.3.2 United States Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Metformin Hydrochloride Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Metformin Hydrochloride Sales Value, 2020-2031
    • 6.4.2 Europe Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Metformin Hydrochloride Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Metformin Hydrochloride Sales Value, 2020-2031
    • 6.5.2 China Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Metformin Hydrochloride Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Metformin Hydrochloride Sales Value, 2020-2031
    • 6.6.2 Japan Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Metformin Hydrochloride Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Metformin Hydrochloride Sales Value, 2020-2031
    • 6.7.2 South Korea Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Metformin Hydrochloride Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Metformin Hydrochloride Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Metformin Hydrochloride Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Metformin Hydrochloride Sales Value, 2020-2031
    • 6.9.2 India Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Metformin Hydrochloride Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Wanbury
    • 7.1.1 Wanbury Company Information
    • 7.1.2 Wanbury Introduction and Business Overview
    • 7.1.3 Wanbury Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Wanbury Metformin Hydrochloride Product Offerings
    • 7.1.5 Wanbury Recent Development
  • 7.2 USV
    • 7.2.1 USV Company Information
    • 7.2.2 USV Introduction and Business Overview
    • 7.2.3 USV Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 USV Metformin Hydrochloride Product Offerings
    • 7.2.5 USV Recent Development
  • 7.3 Shouguang Fukang Pharmaceutical
    • 7.3.1 Shouguang Fukang Pharmaceutical Company Information
    • 7.3.2 Shouguang Fukang Pharmaceutical Introduction and Business Overview
    • 7.3.3 Shouguang Fukang Pharmaceutical Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Shouguang Fukang Pharmaceutical Metformin Hydrochloride Product Offerings
    • 7.3.5 Shouguang Fukang Pharmaceutical Recent Development
  • 7.4 Vistin Pharma
    • 7.4.1 Vistin Pharma Company Information
    • 7.4.2 Vistin Pharma Introduction and Business Overview
    • 7.4.3 Vistin Pharma Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Vistin Pharma Metformin Hydrochloride Product Offerings
    • 7.4.5 Vistin Pharma Recent Development
  • 7.5 Ningxia Hengkang Technology
    • 7.5.1 Ningxia Hengkang Technology Company Information
    • 7.5.2 Ningxia Hengkang Technology Introduction and Business Overview
    • 7.5.3 Ningxia Hengkang Technology Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Ningxia Hengkang Technology Metformin Hydrochloride Product Offerings
    • 7.5.5 Ningxia Hengkang Technology Recent Development
  • 7.6 Keyuan Pharmaceutical
    • 7.6.1 Keyuan Pharmaceutical Company Information
    • 7.6.2 Keyuan Pharmaceutical Introduction and Business Overview
    • 7.6.3 Keyuan Pharmaceutical Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Keyuan Pharmaceutical Metformin Hydrochloride Product Offerings
    • 7.6.5 Keyuan Pharmaceutical Recent Development
  • 7.7 FARMHISPANIA GROUP
    • 7.7.1 FARMHISPANIA GROUP Company Information
    • 7.7.2 FARMHISPANIA GROUP Introduction and Business Overview
    • 7.7.3 FARMHISPANIA GROUP Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 FARMHISPANIA GROUP Metformin Hydrochloride Product Offerings
    • 7.7.5 FARMHISPANIA GROUP Recent Development
  • 7.8 Harman Finochem
    • 7.8.1 Harman Finochem Company Information
    • 7.8.2 Harman Finochem Introduction and Business Overview
    • 7.8.3 Harman Finochem Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Harman Finochem Metformin Hydrochloride Product Offerings
    • 7.8.5 Harman Finochem Recent Development
  • 7.9 Shijiazhuang Polee Pharmaceutical
    • 7.9.1 Shijiazhuang Polee Pharmaceutical Company Information
    • 7.9.2 Shijiazhuang Polee Pharmaceutical Introduction and Business Overview
    • 7.9.3 Shijiazhuang Polee Pharmaceutical Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Shijiazhuang Polee Pharmaceutical Metformin Hydrochloride Product Offerings
    • 7.9.5 Shijiazhuang Polee Pharmaceutical Recent Development
  • 7.10 Aarti Drugs
    • 7.10.1 Aarti Drugs Company Information
    • 7.10.2 Aarti Drugs Introduction and Business Overview
    • 7.10.3 Aarti Drugs Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 Aarti Drugs Metformin Hydrochloride Product Offerings
    • 7.10.5 Aarti Drugs Recent Development
  • 7.11 Exemed Pharmaceuticals
    • 7.11.1 Exemed Pharmaceuticals Company Information
    • 7.11.2 Exemed Pharmaceuticals Introduction and Business Overview
    • 7.11.3 Exemed Pharmaceuticals Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 Exemed Pharmaceuticals Metformin Hydrochloride Product Offerings
    • 7.11.5 Exemed Pharmaceuticals Recent Development
  • 7.12 Granules
    • 7.12.1 Granules Company Information
    • 7.12.2 Granules Introduction and Business Overview
    • 7.12.3 Granules Metformin Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 Granules Metformin Hydrochloride Product Offerings
    • 7.12.5 Granules Recent Development

8 Industry Chain Analysis

  • 8.1 Metformin Hydrochloride Industrial Chain
  • 8.2 Metformin Hydrochloride Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Metformin Hydrochloride Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Metformin Hydrochloride Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Metformin Hydrochloride Market Trends
  • Table 2. Metformin Hydrochloride Market Drivers & Opportunity
  • Table 3. Metformin Hydrochloride Market Challenges
  • Table 4. Metformin Hydrochloride Market Restraints
  • Table 5. Global Metformin Hydrochloride Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Metformin Hydrochloride Revenue Market Share by Company (2020-2025)
  • Table 7. Global Metformin Hydrochloride Sales Volume by Company (2020-2025) & (MT)
  • Table 8. Global Metformin Hydrochloride Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Metformin Hydrochloride Price by Company (2020-2025) & (US$/MT)
  • Table 10. Key Manufacturers Metformin Hydrochloride Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Metformin Hydrochloride Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Metformin Hydrochloride
  • Table 13. Global Metformin Hydrochloride Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metformin Hydrochloride as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Metformin Hydrochloride Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Metformin Hydrochloride Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Metformin Hydrochloride Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Metformin Hydrochloride Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Metformin Hydrochloride Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Metformin Hydrochloride Sales Volume by Type: 2020 VS 2024 VS 2031 (MT)
  • Table 22. Global Metformin Hydrochloride Sales Volume by Type (2020-2025) & (MT)
  • Table 23. Global Metformin Hydrochloride Sales Volume by Type (2026-2031) & (MT)
  • Table 24. Global Metformin Hydrochloride Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Metformin Hydrochloride Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Metformin Hydrochloride Price by Type (2020-2025) & (US$/MT)
  • Table 27. Global Metformin Hydrochloride Price by Type (2026-2031) & (US$/MT)
  • Table 28. Global Metformin Hydrochloride Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Metformin Hydrochloride Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Metformin Hydrochloride Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Metformin Hydrochloride Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Metformin Hydrochloride Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Metformin Hydrochloride Sales Volume by Application: 2020 VS 2024 VS 2031 (MT)
  • Table 34. Global Metformin Hydrochloride Sales Volume by Application (2020-2025) & (MT)
  • Table 35. Global Metformin Hydrochloride Sales Volume by Application (2026-2031) & (MT)
  • Table 36. Global Metformin Hydrochloride Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Metformin Hydrochloride Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Metformin Hydrochloride Price by Application (2020-2025) & (US$/MT)
  • Table 39. Global Metformin Hydrochloride Price by Application (2026-2031) & (US$/MT)
  • Table 40. Global Metformin Hydrochloride Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Metformin Hydrochloride Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Metformin Hydrochloride Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Metformin Hydrochloride Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Metformin Hydrochloride Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Metformin Hydrochloride Sales Volume by Region (MT): 2020 VS 2024 VS 2031
  • Table 46. Global Metformin Hydrochloride Sales Volume by Region (2020-2025) & (MT)
  • Table 47. Global Metformin Hydrochloride Sales Volume by Region (2026-2031) & (MT)
  • Table 48. Global Metformin Hydrochloride Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Metformin Hydrochloride Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Metformin Hydrochloride Average Price by Region (2020-2025) & (US$/MT)
  • Table 51. Global Metformin Hydrochloride Average Price by Region (2026-2031) & (US$/MT)
  • Table 52. Key Countries/Regions Metformin Hydrochloride Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Metformin Hydrochloride Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Metformin Hydrochloride Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Metformin Hydrochloride Sales Volume, (2020-2025) & (MT)
  • Table 56. Key Countries/Regions Metformin Hydrochloride Sales Volume, (2026-2031) & (MT)
  • Table 57. Wanbury Company Information
  • Table 58. Wanbury Introduction and Business Overview
  • Table 59. Wanbury Metformin Hydrochloride Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
  • Table 60. Wanbury Metformin Hydrochloride Product Offerings
  • Table 61. Wanbury Recent Development
  • Table 62. USV Company Information
  • Table 63. USV Introduction and Business Overview
  • Table 64. USV Metformin Hydrochloride Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
  • Table 65. USV Metformin Hydrochloride Product Offerings
  • Table 66. USV Recent Development
  • Table 67. Shouguang Fukang Pharmaceutical Company Information
  • Table 68. Shouguang Fukang Pharmaceutical Introduction and Business Overview
  • Table 69. Shouguang Fukang Pharmaceutical Metformin Hydrochloride Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
  • Table 70. Shouguang Fukang Pharmaceutical Metformin Hydrochloride Product Offerings
  • Table 71. Shouguang Fukang Pharmaceutical Recent Development
  • Table 72. Vistin Pharma Company Information
  • Table 73. Vistin Pharma Introduction and Business Overview
  • Table 74. Vistin Pharma Metformin Hydrochloride Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
  • Table 75. Vistin Pharma Metformin Hydrochloride Product Offerings
  • Table 76. Vistin Pharma Recent Development
  • Table 77. Ningxia Hengkang Technology Company Information
  • Table 78. Ningxia Hengkang Technology Introduction and Business Overview
  • Table 79. Ningxia Hengkang Technology Metformin Hydrochloride Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
  • Table 80. Ningxia Hengkang Technology Metformin Hydrochloride Product Offerings
  • Table 81. Ningxia Hengkang Technology Recent Development
  • Table 82. Keyuan Pharmaceutical Company Information
  • Table 83. Keyuan Pharmaceutical Introduction and Business Overview
  • Table 84. Keyuan Pharmaceutical Metformin Hydrochloride Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
  • Table 85. Keyuan Pharmaceutical Metformin Hydrochloride Product Offerings
  • Table 86. Keyuan Pharmaceutical Recent Development
  • Table 87. FARMHISPANIA GROUP Company Information
  • Table 88. FARMHISPANIA GROUP Introduction and Business Overview
  • Table 89. FARMHISPANIA GROUP Metformin Hydrochloride Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
  • Table 90. FARMHISPANIA GROUP Metformin Hydrochloride Product Offerings
  • Table 91. FARMHISPANIA GROUP Recent Development
  • Table 92. Harman Finochem Company Information
  • Table 93. Harman Finochem Introduction and Business Overview
  • Table 94. Harman Finochem Metformin Hydrochloride Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
  • Table 95. Harman Finochem Metformin Hydrochloride Product Offerings
  • Table 96. Harman Finochem Recent Development
  • Table 97. Shijiazhuang Polee Pharmaceutical Company Information
  • Table 98. Shijiazhuang Polee Pharmaceutical Introduction and Business Overview
  • Table 99. Shijiazhuang Polee Pharmaceutical Metformin Hydrochloride Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
  • Table 100. Shijiazhuang Polee Pharmaceutical Metformin Hydrochloride Product Offerings
  • Table 101. Shijiazhuang Polee Pharmaceutical Recent Development
  • Table 102. Aarti Drugs Company Information
  • Table 103. Aarti Drugs Introduction and Business Overview
  • Table 104. Aarti Drugs Metformin Hydrochloride Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
  • Table 105. Aarti Drugs Metformin Hydrochloride Product Offerings
  • Table 106. Aarti Drugs Recent Development
  • Table 107. Exemed Pharmaceuticals Company Information
  • Table 108. Exemed Pharmaceuticals Introduction and Business Overview
  • Table 109. Exemed Pharmaceuticals Metformin Hydrochloride Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
  • Table 110. Exemed Pharmaceuticals Metformin Hydrochloride Product Offerings
  • Table 111. Exemed Pharmaceuticals Recent Development
  • Table 112. Granules Company Information
  • Table 113. Granules Introduction and Business Overview
  • Table 114. Granules Metformin Hydrochloride Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)
  • Table 115. Granules Metformin Hydrochloride Product Offerings
  • Table 116. Granules Recent Development
  • Table 117. Key Raw Materials Lists
  • Table 118. Raw Materials Key Suppliers Lists
  • Table 119. Metformin Hydrochloride Downstream Customers
  • Table 120. Metformin Hydrochloride Distributors List
  • Table 121. Research Programs/Design for This Report
  • Table 122. Key Data Information from Secondary Sources
  • Table 123. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Metformin Hydrochloride Product Picture
  • Figure 2. Global Metformin Hydrochloride Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Metformin Hydrochloride Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Metformin Hydrochloride Sales Volume (2020-2031) & (MT)
  • Figure 5. Global Metformin Hydrochloride Sales Price (2020-2031) & (US$/MT)
  • Figure 6. Metformin Hydrochloride Report Years Considered
  • Figure 7. Global Metformin Hydrochloride Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Metformin Hydrochloride Players Sales Volume Ranking (2024) & (MT)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Metformin Hydrochloride Revenue in 2024
  • Figure 10. Metformin Hydrochloride Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Metformin HCL Picture
  • Figure 12. Metformin DC Picture
  • Figure 13. Global Metformin Hydrochloride Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Metformin Hydrochloride Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Metformin Hydrochloride Sales Volume by Type (2020 VS 2024 VS 2031) & (MT)
  • Figure 16. Global Metformin Hydrochloride Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Metformin Hydrochloride Price by Type (2020-2031) & (US$/MT)
  • Figure 18. Product Picture of Metformin Hydrochloride Tablets
  • Figure 19. Product Picture of Metformin Hydrochloride Extended-Release Tablets
  • Figure 20. Product Picture of Others
  • Figure 21. Global Metformin Hydrochloride Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 22. Global Metformin Hydrochloride Sales Value Market Share by Application, 2024 & 2031
  • Figure 23. Global Metformin Hydrochloride Sales Volume by Application (2020 VS 2024 VS 2031) & (MT)
  • Figure 24. Global Metformin Hydrochloride Sales Volume Market Share by Application, 2024 & 2031
  • Figure 25. Global Metformin Hydrochloride Price by Application (2020-2031) & (US$/MT)
  • Figure 26. North America Metformin Hydrochloride Sales Value (2020-2031) & (US$ Million)
  • Figure 27. North America Metformin Hydrochloride Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Europe Metformin Hydrochloride Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Europe Metformin Hydrochloride Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Asia Pacific Metformin Hydrochloride Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Asia Pacific Metformin Hydrochloride Sales Value by Region (%), 2024 VS 2031
  • Figure 32. South America Metformin Hydrochloride Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. South America Metformin Hydrochloride Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Middle East & Africa Metformin Hydrochloride Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Middle East & Africa Metformin Hydrochloride Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Key Countries/Regions Metformin Hydrochloride Sales Value (%), (2020-2031)
  • Figure 37. Key Countries/Regions Metformin Hydrochloride Sales Volume (%), (2020-2031)
  • Figure 38. United States Metformin Hydrochloride Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States Metformin Hydrochloride Sales Value by Application (%), 2024 VS 2031
  • Figure 41. Europe Metformin Hydrochloride Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe Metformin Hydrochloride Sales Value by Application (%), 2024 VS 2031
  • Figure 44. China Metformin Hydrochloride Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China Metformin Hydrochloride Sales Value by Application (%), 2024 VS 2031
  • Figure 47. Japan Metformin Hydrochloride Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan Metformin Hydrochloride Sales Value by Application (%), 2024 VS 2031
  • Figure 50. South Korea Metformin Hydrochloride Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea Metformin Hydrochloride Sales Value by Application (%), 2024 VS 2031
  • Figure 53. Southeast Asia Metformin Hydrochloride Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia Metformin Hydrochloride Sales Value by Application (%), 2024 VS 2031
  • Figure 56. India Metformin Hydrochloride Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India Metformin Hydrochloride Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India Metformin Hydrochloride Sales Value by Application (%), 2024 VS 2031
  • Figure 59. Metformin Hydrochloride Industrial Chain
  • Figure 60. Metformin Hydrochloride Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed